Angiotensin Receptor Antagonists

You have accessRestricted Access
Renin-Angiotensin System Blockade after Acute Kidney Injury
Steven Menez and Chirag R. Parikh

CJASN January 2020, 15 (1) 2-4; DOI: https://doi.org/10.2215/CJN.13801119

Add to Selected Citations
You have accessRestricted Access
Renin-Angiotensin System Blockade after Acute Kidney Injury (AKI) and Risk of Recurrent AKI
Chi-yuan Hsu, Kathleen D. Liu, Jingrong Yang, David V. Glidden, Thida C. Tan, Leonid Pravoverov, Sijie Zheng and Alan S. Go

CJASN January 2020, 15 (1) 26-34; DOI: https://doi.org/10.2215/CJN.05800519

Add to Selected Citations
You have accessRestricted Access
Primary Care Prescriptions of Potentially Nephrotoxic Medications in Children with CKD
Claire E. Lefebvre, Kristian B. Filion, Pauline Reynier, Robert W. Platt and Michael Zappitelli

CJASN January 2020, 15 (1) 61-68; DOI: https://doi.org/10.2215/CJN.03550319

Add to Selected Citations
Open Access
Clinical Pharmacology of Antihypertensive Therapy for the Treatment of Hypertension in CKD
Arjun D. Sinha and Rajiv Agarwal

CJASN May 2019, 14 (5) 757-764; DOI: https://doi.org/10.2215/CJN.04330418

Add to Selected Citations
Open Access
Stopping RAS Inhibitors to Minimize AKI
Charles Tomson and Laurie A. Tomlinson

CJASN April 2019, 14 (4) 617-619; DOI: https://doi.org/10.2215/CJN.14021118

Add to Selected Citations
You have accessRestricted Access
Still Asking “Which Rate Is Right?” Years Later
Tyler B. Woodell and Dena E. Rifkin

CJASN December 2018, 13 (12) 1783-1784; DOI: https://doi.org/10.2215/CJN.12371018

Add to Selected Citations
You have accessRestricted Access
Facility-Level Variations in Kidney Disease Care among Veterans with Diabetes and CKD
Sankar D. Navaneethan, Julia M. Akeroyd, David Ramsey, Sarah T. Ahmed, Shiva Raj Mishra, Laura A. Petersen, Paul Muntner, Christie Ballantyne, Wolfgang C. Winkelmayer, Venkat Ramanathan and Salim S. Virani

CJASN December 2018, 13 (12) 1842-1850; DOI: https://doi.org/10.2215/CJN.03830318

Add to Selected Citations
You have accessRestricted Access
Add-On Antihypertensive Medications to Angiotensin-Aldosterone System Blockers in Diabetes
Emily B. Schroeder, Michel Chonchol, Susan M. Shetterly, J. David Powers, John L. Adams, Julie A. Schmittdiel, Gregory A. Nichols, Patrick J. O’Connor and John F. Steiner

CJASN May 2018, 13 (5) 727-734; DOI: https://doi.org/10.2215/CJN.09510817

Add to Selected Citations
You have accessRestricted Access
Diabetic Kidney Disease
Lili Tong and Sharon G. Adler

CJASN February 2018, 13 (2) 335-338; DOI: https://doi.org/10.2215/CJN.04650417

Add to Selected Citations
You have accessRestricted Access
Pooled Analysis of Multiple Crossover Trials To Optimize Individual Therapy Response to Renin-Angiotensin-Aldosterone System Intervention
Sergei I. Petrykiv, Gozewijn Dirk Laverman, Frederik Persson, Liffert Vogt, Peter Rossing, Martin H. de Borst, Ronald T. Gansevoort, Dick de Zeeuw and Hiddo J.L. Heerspink

CJASN November 2017, 12 (11) 1804-1813; DOI: https://doi.org/10.2215/CJN.00390117

Add to Selected Citations

Main menu

User menu

Search

Angiotensin Receptor Antagonists

Pages

About

Author Information

More information